Profound to Showcase TULSA-PRO®, the TULSA Procedure(TM) and the Future of iMRI at AUA2026

Stock Information for EDAP TMS S.A.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About EDAP TMS S.A.

Robotic Radical Prostatectomy Comes Up 'Short' in CAPTAIN Trial
Profound Medical to Release Second Quarter 2026 Financial Results on August 6th - Conference Call to Follow
Profound Medical: Autonomous Robotics and Incisionless Surgery to Have Exceptional Presence at SRS2026
Telix Announces Collaborations to Explore PSMA-PET Imaging in Emerging Prostate Cancer Treatment Approaches
Profound Medical Reports Strong First Quarter 2026 Financial Results
Why Medtech Giants Are Quietly Paying Up for AI Diagnostics
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Profound Medical Corp. - PROF
Profound Medical to Release First Quarter 2026 Financial Results on May 7 - Conference Call to Follow

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.